The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients
Müller, N., Dobmeier, P., Empl, M., Riedel, M. J., Schwarz, M., & Ackenheil, M. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)84789-x · Cited by 62
Self-citationCohen, R. A., de la Monte, S. M., Gongvatana, A., Ombao, H., González, B., Devlin, K. N., NAVIA, B. A., & Tashima, K. T. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.11.006 · Cited by 60
Liu, L., Jia, F., Yuan, G., Chen, Z., Yao, J., Li, H., & Fang, C. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.024 · Cited by 60
Elevated plasma prostaglandin E2 levels in schizophrenia
Kaiya, H., Uematsu, M., Ofuji, M., et al. (1989) · Journal of Neural Transmission · doi:10.1007/bf01255817 · Cited by 60
Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia
Schwab, S. G., Mondabon, S., Knapp, M., Albus, M., Hallmayer, J. F., Borrmann-Hassenbach, M., Trixler, M., Groβ, M., Schulze, T. G., Rietschel, M., et al. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00534-0 · Cited by 58
Association between IL-1β -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia
Zanardini, R., Bocchio‐Chiavetto, L., Scassellati, C., Bonvicini, C., Tura, G. B., Rossi, G., Pérez, J., & Gennarelli, M. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00072-4 · Cited by 58
Sirota, P., Meiman, M. E., Hershko, R., & Bessler, H. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.012 · Cited by 57
Yu, L. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.001 · Cited by 57
Zai, G. C., Müller, D. J., Volavka, J., Czobor, P., Lieberman, J. A., Meltzer, H. Y., & Kennedy, J. L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0482-4 · Cited by 56
Zorrilla, E. P., Cannon, T. D., Gur, R. E., & Kessler, J. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00598-6 · Cited by 56
Das, I., & Khan, N. S. (1998) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(98)90109-0 · Cited by 56
Toyooka, K., Watanabe, Y., Iritani, S., Shimizu, E., Iyo, M., Nakamura, R., Asama, K., Makifuchi, T., Kakita, A., Takahashi, H., et al. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00093-2 · Cited by 55
Welch, K. M. A. (1993) · Cephalalgia · doi:10.1046/j.1468-2982.1993.1305306-3.x · Cited by 55
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers
Rapaport, M. H., McAllister, C. G., Pickar, D., Tamarkin, L., Kirch, D. G., & Paul, S. M. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00008-x · Cited by 54
Dexamethasone Suppression Test
Carroll, B. J. (1984) · Springer eBooks · doi:10.1007/978-94-011-6725-3_1 · Cited by 54
Yeragani, V. K. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500204 · Cited by 54
Dexamethasone suppression test in positive and negative schizophrenia
Altamura, C. A., Guercetti, G., & Percudani, M. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90173-x · Cited by 53
The immune system is a key factor in the etiology of psychosocial disease
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90064-6 · Cited by 50
Papiol, S., Molina, V., Desco, M., Rosa, A., Reig, S., Gispert, J. D., Sanz, J., Palomo, T., & Fañanás, L. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.035 · Cited by 50
Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood
Akagbosu, C., Evans, G. C., Gulick, D., Suckow, R. F., & Bucci, D. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq151 · Cited by 50
Cognitive impairment as a risk factor for psychosis
Reichenberg, A. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/areichenberg · Cited by 49
Pedersen, A., Diedrich, M., Kaestner, F., Koelkebeck, K., Ohrmann, P., Ponath, G. D., Kipp, F., Abel, S., Siegmund, A., Suslow, T., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.017 · Cited by 49
Hinze‐Selch, D., & Pollmächer, T. (2001) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0645 · Cited by 49
Bresee, C. J., & Rapaport, M. H. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000315 · Cited by 48
O׳Donnell, M., Catts, S. V., Ward, P. B., Liebert, B. J., Lloyd, A. R., Wakefield, D., & McConaghy, N. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02824-7 · Cited by 47
Abnormal immune regulation in schizophrenic patients.
Le, D., & Wyatt, R. J. (1982) · PubMed · Cited by 44
Müller, N. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802507852 · Cited by 42
Self-citationTreatment of cognitive deficits in schizophrenia.
Bowie, C. R., & Harvey, P. D. (2006) · PubMed · Cited by 36
Lahdelma, L., Ahokas, A., Andersson, L. C., Suvisaari, J., Hovatta, I., HUTTUNEN, M. O., & Koskimies, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00002 · Cited by 34
Holden, J., Meyers-Manor, J. E., Overmier, J., Gahtan, E., Sweeney, W. A., & Miller, H. C. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.032 · Cited by 33
Nieratschker, V., Frank, J., Mühleisen, T. W., Strohmaier, J., Wendland, J. R., Schumacher, J. H., Treutlein, J., Breuer, R., Jamra, R. A., Mattheisen, M., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.06.018 · Cited by 28
Transforming Growth Factors β1 and β2 in the Cerebrospinal Fluid of Chronic Schizophrenic Patients
Vawter, M. P. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00143-1 · Cited by 26
Interleukin-1β stimulates tyrosine hydroxylase activity in the median eminence
Abreu, P. M., Llorente, E., Hernández, M., & González, M. C. (1994) · Neuroreport · doi:10.1097/00001756-199406000-00016 · Cited by 25
Is there a viral or immune dysfunction etiology to schizophrenia? Re-evaluation a decade later
DeLisi, L. E. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)00061-8 · Cited by 25
Association between interleukin-6 receptor polymorphism and patients with schizophrenia
Sun, S., WANG, F., Cao, L., Qi, L. Y., Xiu, M., CHEN, S., Li, X., WEI, J., Kosten, T. R., & KOSTEN, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.018 · Cited by 25
He, G., Zhang, J., Li, X. W., Chen, W. Y., Pan, Y. X., Yang, F. P., Gu, N. F., Feng, G., Yang, S., He, J. Y., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.06.054 · Cited by 22
Mata, I. F., Crespo‐Facorro, B., Pérez‐Iglesias, R., Carrasco-Marı́n, E., Arranz, M. J., Pelayo‐Terán, J. M., Leyva‐Cobián, F., & Vázquez‐Barquero, J. L. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30405 · Cited by 22
Saviouk, V., Chow, E. W. C., Bassett, A. S., & Brzustowicz, L. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001582 · Cited by 21
The dexamethasone suppression test and negative symptoms of schizophrenia
McGauley, G., Aldridge, C., Fahy, T. A., & Eastment, C. T. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb03024.x · Cited by 11
Cited by
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Self-citationFelger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620
Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
The role of inflammation in schizophrenia
Müller, N., Weidinger, E., Leitner, B., & Schwarz, M. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00372 · Cited by 465
Self-citationMolecular and functional neuroscience in immunity
Pavlov, V. A., Chavan, S. S., & Tracey, K. J. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053158 · Cited by 444
Metadata
- Authors
- Meyer, U., Schwarz, M. J., & Müller, N.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 132
- Issue
- 1
- Pages
- 96-110
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2139161910
- Cited by
- 258
- References
- 239
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.